New PET Tracer Spots More Liver Metastases Than Standard Imaging in Neuroendocrine Tumors
A head-to-head clinical study found that fluorine-18-labeled somatostatin receptor antagonist PET/MR detected substantially more lesions, especially liver metastases, than the ...
